8-KLeadership ChangesExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Executive Changes (Feb 27, 2014)

Filed February 27, 2014For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K on February 26, 2014, detailing compensation arrangements for its executive officers. The Compensation Committee approved payouts for 2013 annual cash bonuses, with amounts detailed for named executive officers. Significantly, the committee also established the performance criteria for 2014 bonuses, focusing on Adjusted Operating Income and a mix of financial (revenue growth, operating margin, earnings per share) and non-financial business objectives. These 2014 incentive plans incorporate specific targets and weighting for revenue growth (including a dedicated component for the Life Sciences Solutions business) and earnings per share, with a multiplier applied to target bonus amounts based on performance outcomes. In addition to bonuses, the filing outlines increases to executive base salaries effective March 31, 2014, and defines target bonus percentages for 2014. The company also granted a significant amount of equity compensation, including time-based and performance-based restricted stock units (RSUs), as well as stock options, to its top executives. The performance-based RSUs are tied to 2014 organic revenue and adjusted earnings per share goals, aligning executive compensation with key operational and financial performance metrics. These actions reflect a structured approach to executive compensation, emphasizing both current performance and long-term alignment with shareholder interests.

Key Highlights

  • 1Approval of 2013 cash bonus payouts for executive officers, with specific amounts disclosed for named executives.
  • 2Establishment of performance criteria for 2014 annual cash bonuses, primarily based on 'Adjusted Operating Income' and a combination of financial and non-financial metrics.
  • 3Detailed 2014 bonus structure includes target cash bonus amounts as a percentage of base salary, ranging from 45% to 180% for named officers.
  • 4Financial performance metrics for 2014 bonuses include revenue growth (with specific weighting for Life Sciences Solutions) and adjusted earnings per share.
  • 5Effective March 31, 2014, executive base salaries were increased, with specific new salary figures provided for named officers.
  • 6Granting of both time-based and performance-based restricted stock units (RSUs) to key executives, with vesting schedules defined.
  • 7Awarding of stock options to executive officers, which vest over a four-year period and have a seven-year term.

Frequently Asked Questions

The Compensation Committee approved the 2013 cash bonus payouts for executives, established the performance criteria for 2014 bonuses, approved salary increases effective March 31, 2014, and granted time-based and performance-based restricted stock units (RSUs) along with stock options to key executives.

For 2014, executive bonuses are linked to 'Adjusted Operating Income' and a blended score of financial metrics (revenue growth, earnings per share, and operating margin) and non-financial business objectives. Performance-based RSUs are specifically tied to 2014 organic revenue (excluding Life Technologies) and adjusted earnings per share.

Executives were granted time-based restricted stock units (RSUs) that vest over a period of up to 42 months, performance-based RSUs tied to specific 2014 financial goals, and stock options that vest over four years and have a seven-year term.

Yes, the Compensation Committee approved increases to the annual base salaries of the company's executive officers, which became effective on March 31, 2014. Specific new salary figures are provided for the named executive officers in the filing.